生存期-话题@MedSci

#生存期#

350篇内容 | 4084人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1378334, encodeId=f7c513e8334aa, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=III期临床研究CheckMate -816证实：纳武利尤单抗联合化疗作为可切除非小细胞肺癌患者新辅助治疗，可显著改善无事件生存期, objectType=article, longId=301595, objectId=0e1630159509, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e1630159509, replyNumber=0, likeNumber=105, createdTime=2022-03-26, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e1630159509, moduleTitle=III期临床研究CheckMate -816证实：纳武利尤单抗联合化疗作为可切除非小细胞肺癌患者新辅助治疗，可显著改善无事件生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e1630159509)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378329, encodeId=3bb313e8329d5, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=JGABSMS：健康的行为、休闲活动和社交网络延长老年糖尿病患者的无残疾生存期, objectType=article, longId=301115, objectId=576430111506, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=576430111506, replyNumber=0, likeNumber=113, createdTime=2022-03-20, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=576430111506, moduleTitle=JGABSMS：健康的行为、休闲活动和社交网络延长老年糖尿病患者的无残疾生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=576430111506)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378328, encodeId=530e13e832877, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Clin Cancer Res：纳武单抗可显著延长晚期食管鳞癌的长期生存期, objectType=article, longId=301037, objectId=1d0d30103eaf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1d0d30103eaf, replyNumber=0, likeNumber=101, createdTime=2022-03-19, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1d0d30103eaf, moduleTitle=Clin Cancer Res：纳武单抗可显著延长晚期食管鳞癌的长期生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1d0d30103eaf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378327, encodeId=c80e13e832767, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Thorac Cancer：ALK阳性是I期完全切除的肺腺癌患者无复发生存期（RFS）负性预测指标, objectType=article, longId=300924, objectId=c0743009248b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0743009248b, replyNumber=0, likeNumber=135, createdTime=2022-03-18, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0743009248b, moduleTitle=Thorac Cancer：ALK阳性是I期完全切除的肺腺癌患者无复发生存期（RFS）负性预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0743009248b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378326, encodeId=530c13e8326bb, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=J Clin Oncol：二次细胞减灭术对铂敏感的复发性卵巢癌患者生存期的影响, objectType=article, longId=299554, objectId=e3252995544f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3252995544f, replyNumber=0, likeNumber=114, createdTime=2022-02-25, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3252995544f, moduleTitle=J Clin Oncol：二次细胞减灭术对铂敏感的复发性卵巢癌患者生存期的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3252995544f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378325, encodeId=b46113e832556, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Lancet Oncol：泊马度胺-地塞米松方案加用Isatuximab可显著延长复发/难治性多发性骨髓瘤患者的总生存期, objectType=article, longId=295593, objectId=ab9629559335, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ab9629559335, replyNumber=0, likeNumber=124, createdTime=2022-02-15, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ab9629559335, moduleTitle=Lancet Oncol：泊马度胺-地塞米松方案加用Isatuximab可显著延长复发/难治性多发性骨髓瘤患者的总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ab9629559335)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378324, encodeId=fd7413e832417, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Med：生酮饮食可增强癌症治疗效果，延长生存期, objectType=article, longId=295591, objectId=1072295591a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1072295591a2, replyNumber=0, likeNumber=93, createdTime=2022-02-15, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1072295591a2, moduleTitle=Med：生酮饮食可增强癌症治疗效果，延长生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1072295591a2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378323, encodeId=37df13e832390, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=NEJM：第三代免疫检查点上场：LAG-3+PD-1，晚期癌症无进展生存期提高一倍, objectType=article, longId=293793, objectId=02ce293e9390, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=02ce293e9390, replyNumber=0, likeNumber=100, createdTime=2022-01-12, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=02ce293e9390, moduleTitle=NEJM：第三代免疫检查点上场：LAG-3+PD-1，晚期癌症无进展生存期提高一倍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02ce293e9390)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378322, encodeId=533113e83223c, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Blood：残余病灶状态对采用不同方案治疗的CLL患者生存期的影响, objectType=article, longId=293568, objectId=04642935685a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04642935685a, replyNumber=0, likeNumber=99, createdTime=2022-01-09, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04642935685a, moduleTitle=Blood：残余病灶状态对采用不同方案治疗的CLL患者生存期的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04642935685a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378321, encodeId=530413e83215a, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Front Onco：基于 MRI 的骨髓放射组学诺模图预测多发性骨髓瘤患者的总生存期, objectType=article, longId=293284, objectId=90c1293284c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=90c1293284c1, replyNumber=0, likeNumber=105, createdTime=2022-01-03, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=90c1293284c1, moduleTitle=Front Onco：基于 MRI 的骨髓放射组学诺模图预测多发性骨髓瘤患者的总生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=90c1293284c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378320, encodeId=d4d913e832040, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=J Clin Oncol：二线化疗联合钇90放射栓塞可显著延长结直肠癌肝转移患者的无进展生存期！, objectType=article, longId=291938, objectId=b40f29193897, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b40f29193897, replyNumber=0, likeNumber=93, createdTime=2021-12-17, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b40f29193897, moduleTitle=J Clin Oncol：二线化疗联合钇90放射栓塞可显著延长结直肠癌肝转移患者的无进展生存期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b40f29193897)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378319, encodeId=560613e83195d, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Clin Cancer Res：晚期肾细胞癌患者免疫治疗停药后的无治疗生存期（TFS）：Check- Mate 214研究, objectType=article, longId=221415, objectId=e7312214158c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e7312214158c, replyNumber=0, likeNumber=93, createdTime=2021-12-03, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e7312214158c, moduleTitle=Clin Cancer Res：晚期肾细胞癌患者免疫治疗停药后的无治疗生存期（TFS）：Check- Mate 214研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e7312214158c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378318, encodeId=06b113e831874, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期, objectType=article, longId=221344, objectId=e1b922134447, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1b922134447, replyNumber=0, likeNumber=79, createdTime=2021-12-02, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1b922134447, moduleTitle=J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1b922134447)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378317, encodeId=b26a13e8317f9, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Front Oncol：化疗对转移性前列腺癌患者的总生存期影响, objectType=article, longId=221253, objectId=76b2221253f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=76b2221253f9, replyNumber=0, likeNumber=108, createdTime=2021-12-01, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=76b2221253f9, moduleTitle=Front Oncol：化疗对转移性前列腺癌患者的总生存期影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76b2221253f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378316, encodeId=865013e8316ff, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=Clin Cancer Res：晚期肾细胞癌免疫+靶向治疗后的无治疗生存期, objectType=article, longId=220642, objectId=32a82206422f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32a82206422f, replyNumber=0, likeNumber=84, createdTime=2021-11-21, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32a82206422f, moduleTitle=Clin Cancer Res：晚期肾细胞癌免疫+靶向治疗后的无治疗生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=32a82206422f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378315, encodeId=cd4613e8315e9, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=AJCD:银屑病治疗中IL - 12/23、IL - 17和IL - 23抑制剂的药物生存期, objectType=article, longId=220062, objectId=c2ab220062ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c2ab220062ff, replyNumber=0, likeNumber=77, createdTime=2021-11-11, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c2ab220062ff, moduleTitle=AJCD:银屑病治疗中IL - 12/23、IL - 17和IL - 23抑制剂的药物生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c2ab220062ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378314, encodeId=ed6613e8314f6, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=CheckMate-816 III期数据公布：非小细胞肺癌患者新辅助治疗，纳武利尤单抗联合化疗可显著改善无事件生存期, objectType=article, longId=220045, objectId=0f6e220045c5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0f6e220045c5, replyNumber=0, likeNumber=94, createdTime=2021-11-11, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f6e220045c5, moduleTitle=CheckMate-816 III期数据公布：非小细胞肺癌患者新辅助治疗，纳武利尤单抗联合化疗可显著改善无事件生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f6e220045c5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378313, encodeId=851e13e831337, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=特发性肺纤维化患者肺康复与生存期相关, objectType=article, longId=220032, objectId=e87e220032bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e87e220032bd, replyNumber=0, likeNumber=114, createdTime=2021-11-11, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e87e220032bd, moduleTitle=特发性肺纤维化患者肺康复与生存期相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e87e220032bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378312, encodeId=aa8a13e8312e9, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=J Clin Oncol：中山大学附属肿瘤医院石明教授团队随机试验证实，采用FOLFOX进行肝动脉灌注化疗可显著延长不可切除的大肝癌患者的生存期！, objectType=article, longId=218768, objectId=3150218e68f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3150218e68f5, replyNumber=0, likeNumber=93, createdTime=2021-10-19, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3150218e68f5, moduleTitle=J Clin Oncol：中山大学附属肿瘤医院石明教授团队随机试验证实，采用FOLFOX进行肝动脉灌注化疗可显著延长不可切除的大肝癌患者的生存期！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3150218e68f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1378311, encodeId=028513e8311fc, content=<a href='/topic/show?id=c29b69004f9' target=_blank style='color:#2F92EE;'>#生存期#</a>, objectTitle=DCR：术前营养评分可以作为 II 至 III 期结直肠癌患者总生存期和术后并发症的预测指标, objectType=article, longId=217965, objectId=b8f721e965b8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b8f721e965b8, replyNumber=0, likeNumber=109, createdTime=2021-10-02, rootId=0, userName=juliusluan78, userId=e68e415, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b8f721e965b8, moduleTitle=DCR：术前营养评分可以作为 II 至 III 期结直肠癌患者总生存期和术后并发症的预测指标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b8f721e965b8)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

生存期

2020-05-29

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

III期临床研究CheckMate -816证实：纳武利尤单抗联合化疗作为可切除非小细胞肺癌患者新辅助治疗，可显著改善无事件生存期

2022-03-26

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

JGABSMS：健康的行为、休闲活动和社交网络延长老年糖尿病患者的无残疾生存期

2022-03-20

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

Clin Cancer Res：纳武单抗可显著延长晚期食管鳞癌的长期生存期

2022-03-19

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

Thorac Cancer：ALK阳性是I期完全切除的肺腺癌患者无复发生存期（RFS）负性预测指标

2022-03-18

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

J Clin Oncol：二次细胞减灭术对铂敏感的复发性卵巢癌患者生存期的影响

2022-02-25

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

Lancet Oncol：泊马度胺-地塞米松方案加用Isatuximab可显著延长复发/难治性多发性骨髓瘤患者的总生存期

2022-02-15

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

Med：生酮饮食可增强癌症治疗效果，延长生存期

2022-02-15

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

NEJM：第三代免疫检查点上场：LAG-3+PD-1，晚期癌症无进展生存期提高一倍

2022-01-12

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

Blood：残余病灶状态对采用不同方案治疗的CLL患者生存期的影响

2022-01-09

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

Front Onco：基于 MRI 的骨髓放射组学诺模图预测多发性骨髓瘤患者的总生存期

2022-01-03

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

J Clin Oncol：二线化疗联合钇90放射栓塞可显著延长结直肠癌肝转移患者的无进展生存期！

2021-12-17

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

Clin Cancer Res：晚期肾细胞癌患者免疫治疗停药后的无治疗生存期（TFS）：Check- Mate 214研究

2021-12-03

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期

2021-12-02

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

Front Oncol：化疗对转移性前列腺癌患者的总生存期影响

2021-12-01

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

Clin Cancer Res：晚期肾细胞癌免疫+靶向治疗后的无治疗生存期

2021-11-21

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

AJCD:银屑病治疗中IL - 12/23、IL - 17和IL - 23抑制剂的药物生存期

2021-11-11

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

CheckMate-816 III期数据公布：非小细胞肺癌患者新辅助治疗，纳武利尤单抗联合化疗可显著改善无事件生存期

2021-11-11

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

特发性肺纤维化患者肺康复与生存期相关

2021-11-11

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

J Clin Oncol：中山大学附属肿瘤医院石明教授团队随机试验证实，采用FOLFOX进行肝动脉灌注化疗可显著延长不可切除的大肝癌患者的生存期！

2021-10-19

juliusluan78 (审核中...)

前往app查看评论内容

#生存期#

DCR：术前营养评分可以作为 II 至 III 期结直肠癌患者总生存期和术后并发症的预测指标

2021-10-02

科室
- - 订阅+
  - 更多科室
工具
服务